{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:06Z","timestamp":1788503526432,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIH NIAID Adjuvant Development Program","doi-asserted-by":"publisher","award":["#HHSN272201300028C"],"award-info":[{"award-number":["#HHSN272201300028C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006610","name":"Michigan Nanotechnology Institute for Medicine and Biological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T13:33:35Z","timestamp":1550583215000},"page":"1591-1600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge"],"prefix":"10.1016","volume":"37","author":[{"given":"Su He","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fattom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/rmv.1846","article-title":"Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif","volume":"25","author":"Luczo","year":"2015","journal-title":"Rev Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.002_b0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12275-017-7062-7","article-title":"H5 influenza, a global update","volume":"55","author":"Harfoot","year":"2017","journal-title":"J Microbiol"},{"issue":"5682","key":"10.1016\/j.vaccine.2019.02.002_b0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.002_b0020","doi-asserted-by":"crossref","first-page":"e01070","DOI":"10.1128\/mBio.01070-14","article-title":"Antigenic variation of clade 2.1 H5N1 virus is determined by a few aminoacid substitutions immediately adjacent to the receptor binding site","volume":"5","author":"Koel","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2019.02.002_b0025","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1128\/JVI.00025-15","article-title":"Antibody titer has positive predictive value for vaccine protection against chal-lenge with natural antigenic drift variants of H5N1 high pathogenicity avianinfluenza viruses from Indonesia","volume":"89","author":"Swayne","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.002_b0030","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"New Eng J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2019.02.002_b0035","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.2014.12609","article-title":"National institute of allergy and infectious diseases-funded vaccine and treatment evaluation units. Immunogenicity of avian influenza A\/Anhui\/01\/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"Belshe","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2019.02.002_b0040","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/v4113227","volume":"4","author":"Chichester","year":"2012","journal-title":"Viruses"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2019.02.002_b0045","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0264-410X(03)00381-5","article-title":"Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion","volume":"21","author":"Myc","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.002_b0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4161\/hv.6.7.11818","article-title":"Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model","volume":"6","author":"Hamouda","year":"2010","journal-title":"Hum Vaccin"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.002_b0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/CVI.00035-11","article-title":"Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant","volume":"18","author":"Hamouda","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"48","key":"10.1016\/j.vaccine.2019.02.002_b0060","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1016\/j.vaccine.2012.09.007","article-title":"Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine","volume":"30","author":"Das","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.002_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.002_b0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2008.11.108","article-title":"Plant-derived hemagglutinin protects ferrets against challenge infection with the A\/Indonesia\/05\/05 strain of avian influenza","volume":"27","author":"Shoji","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1023\/A:1006496308160","article-title":"pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation","volume":"42","author":"Hellens","year":"2000","journal-title":"Plant Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.002_b0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"23","key":"10.1016\/j.vaccine.2019.02.002_b0085","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2008.03.045","article-title":"Plantexpressed HA as a seasonal influenza vaccine candidate","volume":"26","author":"Shoji","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.002_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12175","article-title":"On the mechanism determining the TH1\/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases","volume":"79","author":"Bretscher","year":"2014","journal-title":"Scand J Immunol"},{"issue":"35","key":"10.1016\/j.vaccine.2019.02.002_b0100","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1016\/j.vaccine.2015.03.082","article-title":"Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection","volume":"33","author":"Lai","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.002_b0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/vaccines2040707","article-title":"Overview of serological techniques for influenza vaccine evaluation: past present and future","volume":"2","author":"Trombetta","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.02.002_b0110","unstructured":"Influenza data from World Health Organization. http:\/\/www.who.int\/influenza\/en\/."},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.002_b0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00063030-200822050-00001","article-title":"Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus","volume":"22","author":"Carter","year":"2008","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.002_b0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","article-title":"Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.002_b0125","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/CVI.00373-12","article-title":"Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A\/H5N1 prepandemic influenza vaccine in adult and elderly subjects","volume":"19","author":"Bihari","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2019.02.002_b0130","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"H5N1 pandemic influenza vaccine clinical study team. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"issue":"9523","key":"10.1016\/j.vaccine.2019.02.002_b0135","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial","volume":"367","author":"Bresson","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.002_b0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/mp4005029","article-title":"Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity","volume":"11","author":"Wong","year":"2014","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.002_b0145","doi-asserted-by":"crossref","first-page":"e0126120","DOI":"10.1371\/journal.pone.0126120","article-title":"Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based Intranasal vaccine adjuvants","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2217\/nnm.11.187","article-title":"Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen","volume":"7","author":"Wang","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.vaccine.2019.02.002_b0155","first-page":"S0264-","article-title":"Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines","author":"Allen","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2016.12.053","article-title":"Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: a Phase 2 trial","volume":"35","author":"Treanor","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.002_b0165","doi-asserted-by":"crossref","first-page":"e0131652","DOI":"10.1371\/journal.pone.0131652","article-title":"H5N1 vaccine induces cross-H5 clade humoral immune responses in a randomized clinical trial and provides protection from highly pathogenic influenza challenge in ferrets","volume":"10","author":"Cox","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.002_b0170","first-page":"1235","article-title":"Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge","volume":"11","author":"Major","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.002_b0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/pbi.12235","article-title":"Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection","volume":"13","author":"Lee","year":"2015","journal-title":"Plant Biotechnol J"},{"issue":"48","key":"10.1016\/j.vaccine.2019.02.002_b0180","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2013.08.064","article-title":"Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5\/Indonesia\/05\/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant","volume":"31","author":"Treanor","year":"2013","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2019.02.002_b0185","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1016\/j.vaccine.2010.09.033","article-title":"The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice","volume":"28","author":"Fraternale","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.002_b0190","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.002_b0195","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/jiq093","article-title":"Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant","volume":"203","author":"Belshe","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.002_b0200","doi-asserted-by":"crossref","first-page":"44727","DOI":"10.1038\/srep44727","article-title":"The immune correlates of protection for an avian influenzaH5N1 vaccine in the ferret model using oil-in-water adjuvants","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.002_b0205","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.002_b0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/cmi.2011.38","article-title":"A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.002_b0215","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.4049\/jimmunol.0900657","article-title":"IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge","volume":"182","author":"McKinstry","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.002_b0220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1128\/IAI.00984-10","article-title":"Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia","volume":"79","author":"Scurlock","year":"2011","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2019.02.002_b0225","doi-asserted-by":"crossref","first-page":"22361","DOI":"10.18632\/oncotarget.15652","article-title":"Neutralization of interleukin-17 suppresses allergic rhinitis symptoms by downregulating Th2 and Th17 responses and upregulating the Treg response","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2019.02.002_b0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"Hannoun","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.002_b0235","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2007.06.060","article-title":"Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine","volume":"25","author":"Asanuma","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:57:02Z","timestamp":1606535822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19301689"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}